ArticleRheumatology (Oxford, England)2023

Long-term safety and efficacy of sarilumab with or without background csDMARDs in rheumatoid arthritis.

Gerd R Burmester et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.